Tectonic Therapeutic, Inc., a clinical stage biotechnology company specializing in therapeutic proteins and antibodies that target G-protein coupled receptors (GPCRs), has announced its inclusion in ...
WATERTOWN, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (TECX) (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of ...
SAN DIEGO and SUZHOU, China, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced data at the ...
Despite the approval of numerous antibody-drug conjugates (ADCs), their therapeutic index remains limited by off-target toxicity resulting from linker instability. To address this challenge, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results